Atlantic International Corp. (ATLN)
NASDAQIndustrialsMedical - PharmaceuticalsSnapshot 2026-09-04
$0.90-2.16%
Close 2026-07-01 · 1-day change
NASDAQIndustrialsMedical - PharmaceuticalsSnapshot 2026-09-04
Intact: The reason to own it still holds.
Atlantic aims to grow revenue to $1 billion in 2026. It won a $52 million Dutch contract. Management is making key leadership changes. The company is completing acquisitions to grow.
The company is losing money and faces legal and credit problems. Revenue estimates for 2026 show no growth. Leadership changes may not fix deep issues.
The market has sold off sharply, reflecting worries about losses and risks. There is no clear consensus revenue growth priced in. Our view sees potential if revenue hits $1 billion.
Breaks if: Additional key executive departures or instability in 2026
Breaks if: Revenue falls below $780 million in 2026
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This is a speculative growth investment with a focus on potential recovery. The current thesis state reflects a cautious outlook due to recent operational struggles and regulatory challenges.
The market appears to be pricing in significant uncertainty given the company's loss-making status and recent earnings misses. Expectations may be low, but the potential for recovery hinges on management's ability to execute their growth strategies.
Fundamentals are likely to remain weak in the near term, especially with a high probability of an earnings miss. Management is working on achieving revenue targets and addressing financial obligations, but challenges persist.
The long-term thesis hinges on the performance of sector bellwethers and ATLN's ability to meet its revenue goals. Any cuts to guidance or further earnings misses could negatively impact sentiment.
The most important moves since the prior daily snapshot.
Our read on the company is unchanged since the prior snapshot.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Reach $1 billion in annual revenue organically in 2026, building on Circle8 acquisition and expanded platform.
Stated as a priority in 3 recent quarters. Revenue grew from $102.8 million in 2025-Q1 to $249.9 million in 2026-Q1 (+143%), with combined operations exceeding $1.1 billion annualized revenue by 2026-Q2. Management is delivering on the $1 billion revenue target for 2026, reflecting successful integration of Circle8.
“Combined operations now exceed $1.1 billion in annualized revenue.”
“Revenue increased 143% to approximately $249.9 million, reflecting Circle8 acquisition.”
“Circle8 generated approximately $780 million in revenue in 2025 and is on track to reach $1 billion organically in 2026.”
Breaks if: Failure to complete key acquisitions by end of 2026
Continue executing strategic acquisitions including Circle8 to expand geographic reach and capabilities.
Stated in 3 recent quarters, management has completed the Circle8 acquisition in early 2026 and continues to pursue strategic M&A to expand scale and capabilities. The integration of Circle8 is reflected in revenue growth and expanded geographic reach, indicating progress on this priority.
“The quarter reflects the first contribution of Circle8 Group following the completion of the acquisition on January 23, 2026.”
“Atlantic International Corp entered into a Securities Purchase Agreement for preferred stock in March 2026.”
“Management emphasized strategic acquisitions including Lyneer and Circle8 reshaping the company.”
In the next 1 to 3 years, ATLN's outlook will depend on its execution of strategic priorities and external sector conditions. Not investment advice.